← Evidence map

TrialNature communications2022

An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion.

Caroline Gubser Keller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

71 papers cite itlatest 60 shown

2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35241644